FDA Approvals in Oncology: April-June 2024
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...